Skip to main content
Journal cover image

Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis

Publication ,  Journal Article
Lynd, LD; Colley, L; Najafzedeh, M; Sculpher, MJ; Willan, AR; Johnson, RF; Ozdemir, S
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
August 1, 2007

Duke Scholars

Published In

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

ISSN

1053-8569

Publication Date

August 1, 2007

Volume

16

Start / End Page

S183 / S183

Publisher

JOHN WILEY & SONS LTD

Related Subject Headings

  • Pharmacology & Pharmacy
  • 4202 Epidemiology
  • 3214 Pharmacology and pharmaceutical sciences
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lynd, L. D., Colley, L., Najafzedeh, M., Sculpher, M. J., Willan, A. R., Johnson, R. F., & Ozdemir, S. (2007). Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 16, S183–S183.
Lynd, Larry D., Lindsey Colley, Mehdi Najafzedeh, Mark J. Sculpher, Andrew R. Willan, Reed F. Johnson, and Semra Ozdemir. “Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 16 (August 1, 2007): S183–S183.
Lynd LD, Colley L, Najafzedeh M, Sculpher MJ, Willan AR, Johnson RF, et al. Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2007 Aug 1;16:S183–S183.
Lynd, Larry D., et al. “Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 16, JOHN WILEY & SONS LTD, Aug. 2007, pp. S183–S183.
Lynd LD, Colley L, Najafzedeh M, Sculpher MJ, Willan AR, Johnson RF, Ozdemir S. Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. JOHN WILEY & SONS LTD; 2007 Aug 1;16:S183–S183.
Journal cover image

Published In

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

ISSN

1053-8569

Publication Date

August 1, 2007

Volume

16

Start / End Page

S183 / S183

Publisher

JOHN WILEY & SONS LTD

Related Subject Headings

  • Pharmacology & Pharmacy
  • 4202 Epidemiology
  • 3214 Pharmacology and pharmaceutical sciences
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences